These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38557323)

  • 1. Genomic characterisation of clinically significant blood group variants in Aboriginal Australians.
    Jadhao S; Davison C; Roulis E; Lee S; Campbell T; Griffin R; Toombs M; Brown A; Perry M; Nasir B; Irving DO; Hyland CA; Flower RL; Nagaraj SH
    Blood Transfus; 2024 Mar; ():. PubMed ID: 38557323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes.
    Scott SA; Nagl L; Tilley L; Liew YW; Condon J; Flower R; Hyland CA
    Transfusion; 2014 Nov; 54(11):2931-40. PubMed ID: 24894016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype analysis to clarify RhD variants in discrepant samples of Chilean population.
    Aburto A; Zapata D; Retamales E; Fernández J; Barra G; Peña F; Cárcamo S; Saavedra N; Sandoval C; Orellana J; Caamaño J
    Front Immunol; 2023; 14():1299639. PubMed ID: 38116010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genomic landscape of blood groups in Indigenous Australians in remote communities.
    Jadhao S; Hoy W; Lee S; Patel HR; McMorran BJ; Flower RL; Nagaraj SH
    Transfusion; 2022 May; 62(5):1110-1120. PubMed ID: 35403234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.
    Wang QP; Dong GT; Wang XD; Gu J; Li Z; Sun AY; Shao CP; Pan ZL; Huang LH; Xie WX; Sun GM; Chen JJ; Pei H; Yang XJ; Shan PN
    Blood Transfus; 2014 Apr; 12(2):238-43. PubMed ID: 23399369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and characterization of RHD variant alleles in a population of blood donors from southeastern Brazil: Comparison with other populations.
    Rodrigues ES; Romagnoli AC; Santos FLS; Cutter TB; Catelli LF; Cédric V; Peyrard T; Covas DT; de Castilho LM; Kashima S
    Transfus Apher Sci; 2021 Aug; 60(4):103135. PubMed ID: 33867285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.
    El Housse H; El Wafi M; Ouabdelmoumene Z; Zarati F; Alid R; Nourichafi N; Bouisk K; Benajiba M; Férec C; Fichou Y; Habti N
    Blood Transfus; 2019 Mar; 17(2):151-156. PubMed ID: 30418133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen.
    Souza Silva TC; Cruz BR; Costa SS; Chiba AK; Barros MMO; Langhi DM; Bordin JO
    Blood Transfus; 2020 Jul; 18(4):295-303. PubMed ID: 32697929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation of RhD variants in North Indian blood donor population.
    Khetan D; Verma A; Chaudhary RK; Shukla JS
    Transfus Med; 2020 Aug; 30(4):295-303. PubMed ID: 32488899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.
    McGowan EC; Lopez GH; Knauth CM; Liew YW; Condon JA; Ramadi L; Parsons K; Turner EM; Flower RL; Hyland CA
    Vox Sang; 2017 Apr; 112(3):279-287. PubMed ID: 28220510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive blood group antigen profile predictions for Western Desert Indigenous Australians from whole exome sequence data.
    Schoeman EM; Roulis EV; Perry MA; Flower RL; Hyland CA
    Transfusion; 2019 Feb; 59(2):768-778. PubMed ID: 30520525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHD variants in Flanders, Belgium.
    Van Sandt VS; Gassner C; Emonds MP; Legler TJ; Mahieu S; Körmöczi GF
    Transfusion; 2015 Jun; 55(6 Pt 2):1411-7. PubMed ID: 25413499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHCE variants inherited with altered RHD alleles in Brazilian blood donors.
    Prisco Arnoni C; Guilhem Muniz J; de Paula Vendrame TA; de Medeiros Person R; Roche Moreira Latini F; Castilho L
    Transfus Med; 2016 Aug; 26(4):285-90. PubMed ID: 27111588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic RH genotyping and variant identification in French donors of African origin.
    Kappler-Gratias S; Auxerre C; Dubeaux I; Beolet M; Ripaux M; Le Pennec PY; Pham BN
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s264-72. PubMed ID: 23867180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for DEL phenotype in RhD negative Indians.
    Kulkarni S; Parchure DS; Gopalkrishnan V; Madkaikar M
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28643361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RHD genotyping of serological weak D phenotypes in the Iranian blood donors and patients.
    Oodi A; Daneshvar Z; Goudarzi S; Amirizadeh N
    Transfus Apher Sci; 2020 Oct; 59(5):102870. PubMed ID: 32660892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of DEL phenotype in RhD negative donor population of north India.
    Samir S; Jain A; Marwaha N
    Transfus Apher Sci; 2015 Aug; 53(1):34-7. PubMed ID: 25818997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China.
    Zhang X; Li G; Zhou Z; Shao C; Huang X; Li L; Li X; Liu Y; Fan H; Li J
    J Transl Med; 2019 Nov; 17(1):393. PubMed ID: 31775789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting.
    Maryam DU; Mukhtar IG; Yusuf AA; Salisu AI
    Hematol Transfus Cell Ther; 2022; 44(3):386-391. PubMed ID: 33744228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.